These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 9453429
1. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, Sjövall J. J Hepatol; 1997 Dec; 27(6):1029-40. PubMed ID: 9453429 [Abstract] [Full Text] [Related]
2. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjövall J. Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000 [Abstract] [Full Text] [Related]
3. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, Sjövall J. J Hepatol; 1997 Aug; 27(2):346-57. PubMed ID: 9288610 [Abstract] [Full Text] [Related]
4. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]. Brites D, Rodrigues CM. J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912 [Abstract] [Full Text] [Related]
5. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Reyes H, Sjövall J. Ann Med; 2000 Mar; 32(2):94-106. PubMed ID: 10766400 [Abstract] [Full Text] [Related]
6. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM. J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870 [Abstract] [Full Text] [Related]
7. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Hepatology; 2008 Feb; 47(2):544-51. PubMed ID: 17968976 [Abstract] [Full Text] [Related]
8. Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy. Estiú MC, Monte MJ, Rivas L, Moirón M, Gomez-Rodriguez L, Rodriguez-Bravo T, Marin JJ, Macias RI. Br J Clin Pharmacol; 2015 Feb; 79(2):316-29. PubMed ID: 25099365 [Abstract] [Full Text] [Related]
9. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Rodrigues CM, Marín JJ, Brites D. Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117 [Abstract] [Full Text] [Related]
10. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Brites D. Ann Hepatol; 2002 Sep; 1(1):20-8. PubMed ID: 15114292 [Abstract] [Full Text] [Related]
11. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325 [Abstract] [Full Text] [Related]
12. The identification of novel steroid N-acetylglucosaminides in the urine of pregnant women. Meng LJ, Griffiths WJ, Sjövall J. J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):585-98. PubMed ID: 8918986 [Abstract] [Full Text] [Related]
13. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term. Keitel V, Spomer L, Marin JJ, Williamson C, Geenes V, Kubitz R, Häussinger D, Macias RI. Placenta; 2013 Sep; 34(9):810-6. PubMed ID: 23849932 [Abstract] [Full Text] [Related]
14. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C. BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939 [Abstract] [Full Text] [Related]
15. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. Almé B, Bremmelgaard A, Sjövall J, Thomassen P. J Lipid Res; 1977 May; 18(3):339-62. PubMed ID: 864325 [Abstract] [Full Text] [Related]
16. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid. Piazza F, Montagnani M, Russo C, Azzaroli F, Aldini R, Roda E, Roda A. Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630 [Abstract] [Full Text] [Related]
17. Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy. Thomassen PA. Eur J Clin Invest; 1979 Dec; 9(6):425-32. PubMed ID: 119641 [Abstract] [Full Text] [Related]
18. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Abu-Hayyeh S, Papacleovoulou G, Lövgren-Sandblom A, Tahir M, Oduwole O, Jamaludin NA, Ravat S, Nikolova V, Chambers J, Selden C, Rees M, Marschall HU, Parker MG, Williamson C. Hepatology; 2013 Feb; 57(2):716-26. PubMed ID: 22961653 [Abstract] [Full Text] [Related]
20. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid. Fracchia M, Setchell KD, Crosignani A, Podda M, O'Connell N, Ferraris R, Hofmann AF, Galatola G. Clin Chim Acta; 1996 Apr 30; 248(2):175-85. PubMed ID: 8740581 [Abstract] [Full Text] [Related] Page: [Next] [New Search]